← SynDRA
TOLMETIN
SynDRA canonical compound SYN0003185 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | PTGS2 |
| Mechanism of action | Cyclooxygenase inhibitor |
| Indication | osteoarthritis | rheumatoid arthritis |
| Disease area | rheumatology |
All known targets
- PTGS2
- PTGS1
- AKR1B1
- Akr1b1
- CXCL8
- GLO1
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- M02A · TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- tolmetin sodium anhydrous
- tolmetine
- tolmetin sodium
- tolmetin sodium salt
- tolmetin sodium salt dihydrate
- Tolmetine
- Tolmetina
- MCN-2559
- Tolectin
- Tolmetino
- Tolmetinum
- Tolmetina [DCIT]
- McN-2559
- Tolectin (TN)
- Tolmetin Sodium, Dihydrate
- Tolmetine [INN-French]
- Tolmetino [INN-Spanish]
- Tolmetinum [INN-Latin]
- Tolmetin (USAN/INN)
- Tolmetin [USAN:BAN:INN]
- Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico
- Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico [Spanish]
- 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid
- 1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid
- 1-Methyl-5-p-toluoylpyrrole-2-acetic acid
- 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid
- 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid
- D8K2JPN18B
- MCN 2559
- tolectin
- 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-
- 2-(1-METHYL-5-(4-METHYLBENZOYL)-1H-PYRROL-2-YL)ACETIC ACID
- 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid
- Pyrrole-2-acetic acid, 1-methyl-5-p-toluoyl-
- CHEBI:71941
- 5-22-06-00392 (Beilstein Handbook Reference)
- McN2559
- Sodium, Tolmetin
Look up TOLMETIN in the interactive SynDRA portal →